Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
CD8 T 细胞依赖性红细胞前阶段疟疾疫苗的生物学知情设计
基本信息
- 批准号:10341058
- 负责人:
- 金额:$ 129.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-04 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimal ModelAntigen PresentationAntigen-Presenting CellsAntigensAttenuatedAttenuated VaccinesBasic ScienceBehaviorBiologicalBiological AssayBiologyBiomassCD8-Positive T-LymphocytesCRISPR/Cas technologyCell Cycle KineticsCellsCellular biologyCessation of lifeClinical TrialsCross PresentationDataDevelopmentDominant-Negative MutationEnsureEpitopesErythrocytesGene DeletionGenerationsGenetic EngineeringGenome engineeringHepatocyteHumanImmuneImmune responseImmunityImmunizationImmunizeImmunologicsIn VitroInfectionKnowledgeLiverMHC Class I GenesMalariaMalaria VaccinesMediatingModelingMolecularMusParasitesPeptidesPhasePlasmodiumPlasmodium falciparumPlasmodium falciparum vaccinePlasmodium vaccinePlasmodium yoeliiProcessProteinsProteomeProteomicsRadiationRodentSporozoitesSubunit VaccinesSurfaceSurface AntigensT cell responseT-Cell ActivationT-Lymphocyte EpitopesTechnologyTestingTimeTissuesTransgenesTranslational ResearchVaccinationVaccine DesignVaccinesViral VectorWorkattenuationbasecell killingdesigngenomic locusimmunogenicityliver infectionmalaria infectionnext generationoverexpressionparasite genomepromoterresponsetooltranscriptomevaccine candidatevaccine efficacyvaccine immunogenicityvectorvector vaccine
项目摘要
PROJECT SUMMARY/ABSTRACT
Immunization with whole pre-erythrocytic (sporozoite and liver stage) Plasmodium falciparum (Pf)
vaccines confers sterilizing immunity in human clinical trials. Replication-deficient vaccines, such as radiation-
attenuated sporozoites infect the liver as sporozoites but do not develop into liver stage schizonts. Replication-
competent vaccines, however, infect the liver and replicate as tissue schizonts. Multiple lines of evidence in
animal models of malaria have shown that protection is dependent on antigen-specific CD8+ T cells that
recognize liver stage-infected hepatocytes, leading to their elimination. Replication-competent parasite
vaccination confers superior durable sterilizing immunity against infection, and this appears to be, in animal
models, associated with broader and better CD8+ T cell responses. However, it remains largely unknown how
the distinct molecular cell biological features of whole attenuated parasite vaccines drive differences in the
priming of protective CD8+ T cells and of equal importance, which liver stage antigens are directly presented by
wildtype liver stage-infected hepatocytes that are the targets of vaccine-elicited protective CD8+ T cells. We will
address these critical knowledge gaps. In Aim 1, we will identify the distinct time points during which the demise
of liver stage-infected hepatocytes results in optimal cross-presentation of liver stage antigens by antigen
presenting cells to CD8+ T cells. For this, we will use the Plasmodium yoelii (Py) rodent malaria model to inform
vaccine design of Pf, with which mechanistic host studies cannot be done. We will also determine at what time
points of wildtype liver stage development infected hepatocytes are most vulnerable to effector CD8+ T cell-
mediated elimination. In concert with this, we will determine dynamic liver stage transcriptomes and proteomes
throughout development and down-select the subset of liver stage proteins most prone to intrahepatocytic
processing and MHC class I-restricted peptide presentation. In Aim 2, we will directly determine the MHC class
I peptidome of Py and Pf presented on infected hepatocytes, specifically at timepoints of highest vulnerability
and test their reactivity with whole parasite-vaccine-elicited CD8+ T cells. We will then test reactive epitopes as
well as nonreactive epitopes (covert epitopes) as vectored subunit vaccines in mice. As in Aim 1, mechanistic
testing cannot be done in Pf and thus we will conduct studies of Py to guide our Pf work. In Aim 3, we will
genetically engineer the ultimate Pf replication-competent parasite strain that is built with gene deletions and
dominant negative transgenes of parasite origin and will also over-express protective CD8+ T cell epitopes that
target liver stages at the point of their greatest vulnerability. Thus, in a multi-pronged approach our project will
develop the next generation of pre-erythrocytic vaccines including both vectored subunit vaccine candidates and
whole genetically attenuated parasite vaccine candidates, designed to generate optimal and durable protective
CD8+ T cell responses against Pf infection.
项目总结/摘要
用整个红细胞前(子孢子和肝阶段)恶性疟原虫(Pf)免疫
疫苗在人体临床试验中赋予了杀菌免疫力。复制缺陷疫苗,如辐射-
减毒的子孢子以子孢子的形式感染肝脏,但不发育成肝脏阶段的子孢子。复制-
然而,合格的疫苗感染肝脏并作为组织复制体进行复制。多条线索的证据
疟疾的动物模型显示,保护作用依赖于抗原特异性CD 8 + T细胞,
识别肝脏阶段感染的肝细胞,导致其消除。有复制能力的寄生虫
疫苗接种赋予针对感染的优越的上级持久的灭菌免疫力,这似乎是,在动物中
模型,与更广泛和更好的CD 8 + T细胞反应相关。然而,在很大程度上仍然不知道如何
全减毒寄生虫疫苗的不同分子细胞生物学特征驱动了
启动保护性CD 8 + T细胞,同样重要的是,肝脏阶段抗原直接由
野生型肝脏阶段感染的肝细胞是疫苗诱导的保护性CD 8 + T细胞的靶。我们将
解决这些关键的知识差距。在目标1中,我们将确定死亡的不同时间点,
肝期感染肝细胞的最佳交叉呈递肝期抗原
向CD 8 + T细胞呈递细胞。为此,我们将使用约氏疟原虫(Py)啮齿动物疟疾模型来告知
Pf的疫苗设计,用其不能进行机理宿主研究。我们还将确定
野生型肝发育阶段感染的肝细胞最容易受到效应CD 8 + T细胞的影响,
介导的消除。与此同时,我们将确定动态肝脏阶段转录组和蛋白质组
在整个发育过程中,向下选择最倾向于肝内细胞凋亡的肝阶段蛋白质的子集,
加工和MHC I类限制性肽呈递。在目标2中,我们将直接确定MHC类别
Py和Pf的I肽组呈现在感染的肝细胞上,特别是在最高脆弱性的时间点
并测试它们与完整寄生虫疫苗诱导的CD 8 + T细胞的反应性。然后我们将测试反应性表位,
以及非反应性表位(隐蔽表位)作为小鼠中的载体亚单位疫苗。如目标1,机械性
Pf无法进行测试,因此我们将对Py进行研究,以指导我们的Pf工作。在目标3中,我们
基因工程改造最终的Pf复制能力寄生虫菌株,该菌株是用基因缺失构建的,
寄生虫来源的显性负转基因,并且还将过表达保护性CD 8 + T细胞表位,
针对肝脏最脆弱的阶段。因此,在多管齐下的方法,我们的项目将
开发下一代红细胞前疫苗,包括载体亚单位疫苗候选物,
全基因减毒寄生虫疫苗候选物,旨在产生最佳和持久的保护作用,
针对Pf感染的CD 8 + T细胞应答。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stefan HI Kappe其他文献
Stefan HI Kappe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stefan HI Kappe', 18)}}的其他基金
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
寄生虫和宿主细胞因子参与间日疟原虫休眠子的形成和持续存在
- 批准号:
10564073 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
CD8 T 细胞依赖性红细胞前阶段疟疾疫苗的生物学知情设计
- 批准号:
10558591 - 财政年份:2021
- 资助金额:
$ 129.83万 - 项目类别:
Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
评估 SARS-CoV-2 感染人类受试者持久保护性免疫力的决定因素
- 批准号:
10265628 - 财政年份:2020
- 资助金额:
$ 129.83万 - 项目类别:
Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
评估 SARS-CoV-2 感染人类受试者持久保护性免疫力的决定因素
- 批准号:
10375774 - 财政年份:2019
- 资助金额:
$ 129.83万 - 项目类别:
Inducing durable, protective immune memory against malaria
诱导针对疟疾的持久、保护性免疫记忆
- 批准号:
10084807 - 财政年份:2019
- 资助金额:
$ 129.83万 - 项目类别:
Inducing durable, protective immune memory against malaria
诱导针对疟疾的持久、保护性免疫记忆
- 批准号:
10545746 - 财政年份:2019
- 资助金额:
$ 129.83万 - 项目类别:
Molecular Determinants of Sporozoite / Host Cell Interactions
子孢子/宿主细胞相互作用的分子决定因素
- 批准号:
10192640 - 财政年份:2018
- 资助金额:
$ 129.83万 - 项目类别:
Refining Mendelian genetics of malaria parasites
完善疟疾寄生虫的孟德尔遗传学
- 批准号:
10216647 - 财政年份:2017
- 资助金额:
$ 129.83万 - 项目类别:
相似国自然基金
基于口腔-肠道菌群构建胆囊癌早期诊断及实验动物模型
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
京尼平在阻止豚鼠离焦性近视进展中的作用及其机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
碳青霉烯类药物诱导下的CRPA对于头孢他啶-阿维巴坦耐药性影响机制分析及动物模型构建研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
自闭谱系障碍小鼠恐惧异常的小脑环路机制研究
- 批准号:MS25C090020
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于人源化动物模型解析核苷酸重复扩增致病机制
- 批准号:2025JJ20079
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于裸鼠动物模型探讨外泌体circMYCBP2调控PARylation修饰促进胶质母细胞瘤TMZ耐药的作用及机制研究
- 批准号:MS25C040009
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
2 型 Dent 病足细胞损伤动物模型的建立及其
分子机制研究
- 批准号:TGD24H050002
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
TSH 异常波动介导的 TAO 动物模型的构建及
其机制探索
- 批准号:TGD24H120004
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
靶向CLDN18.2的抗原嵌合受体-巨噬细胞在胃癌动物模型治疗中的应用研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于多模态数据整合的儿童颞叶癫痫miR-155-5p/DUSP14/MAPK通路表达及炎症损伤机制的多中心临床与动物模型研究
- 批准号:2024Y9075
- 批准年份:2024
- 资助金额:50.0 万元
- 项目类别:省市级项目
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 129.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists